 | • レポートコード：20QY06-07146 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、多価肺炎球菌ワクチンのグローバル市場について種類別（プレベナー13、ニューモバックス23）、用途別（18歳以下、19〜64歳、65歳以上）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・多価肺炎球菌ワクチン市場の概要 ・世界の主要地域別多価肺炎球菌ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の多価肺炎球菌ワクチン市場規模2015-2026：種類別（プレベナー13、ニューモバックス23） ・世界の多価肺炎球菌ワクチン市場規模2015-2026：用途別（18歳以下、19〜64歳、65歳以上） ・多価肺炎球菌ワクチンの北米市場規模2015-2020 ・多価肺炎球菌ワクチンのヨーロッパ市場規模2015-2020 ・多価肺炎球菌ワクチンの中国市場規模2015-2020 ・多価肺炎球菌ワクチンの日本市場規模2015-2020 ・多価肺炎球菌ワクチンの東南アジア市場規模2015-2020 ・多価肺炎球菌ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Merck & Co.、Pfizer） ・多価肺炎球菌ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・多価肺炎球菌ワクチンの市場動向・機会・課題 ・調査の結論 |
Pneumococcal vaccines are vaccines against the bacteria Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis.
Market Analysis and Insights: Global Pneumococcal Vaccine Polyvalent Market
The global Pneumococcal Vaccine Polyvalent market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Pneumococcal Vaccine Polyvalent Scope and Market Size
The global Pneumococcal Vaccine Polyvalent market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pneumococcal Vaccine Polyvalent market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Pneumococcal Vaccine Polyvalent market is segmented into
Prevnar 13
Pneumovax23
Segment by Application, the Pneumococcal Vaccine Polyvalent market is segmented into
18 years and younger
19 to 64 years old
65 years and older
The Pneumococcal Vaccine Polyvalent market is analysed and market size information is provided by regions (countries). Segment by Application, the Pneumococcal Vaccine Polyvalent market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pneumococcal Vaccine Polyvalent Market Share Analysis
Pneumococcal Vaccine Polyvalent market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pneumococcal Vaccine Polyvalent business, the date to enter into the Pneumococcal Vaccine Polyvalent market, Pneumococcal Vaccine Polyvalent product introduction, recent developments, etc.
The major vendors covered:
Merck & Co.
Pfizer
…
Table of Contents
1 Pneumococcal Vaccine Polyvalent Market Overview
1.1 Pneumococcal Vaccine Polyvalent Product Scope
1.2 Pneumococcal Vaccine Polyvalent Segment by Type
1.2.1 Global Pneumococcal Vaccine Polyvalent Sales by Type (2020-2026)
1.2.2 Prevnar 13
1.2.3 Pneumovax23
1.3 Pneumococcal Vaccine Polyvalent Segment by Application
1.3.1 Global Pneumococcal Vaccine Polyvalent Sales Comparison by Application (2020-2026)
1.3.2 18 years and younger
1.3.3 19 to 64 years old
1.3.4 65 years and older
1.4 Pneumococcal Vaccine Polyvalent Market Estimates and Forecasts (2015-2026)
1.4.1 Global Pneumococcal Vaccine Polyvalent Sales Growth Rate (2015-2026)
1.4.2 Global Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2015-2026)
1.4.3 Global Pneumococcal Vaccine Polyvalent Price Trends (2015-2026)
2 Pneumococcal Vaccine Polyvalent Estimate and Forecast by Region
2.1 Global Pneumococcal Vaccine Polyvalent Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Pneumococcal Vaccine Polyvalent Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Pneumococcal Vaccine Polyvalent Sales Market Share by Region (2015-2020)
2.2.2 Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Region (2015-2020)
2.3 Global Pneumococcal Vaccine Polyvalent Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Pneumococcal Vaccine Polyvalent Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Pneumococcal Vaccine Polyvalent Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Pneumococcal Vaccine Polyvalent Estimates and Projections (2015-2026)
2.4.2 Europe Pneumococcal Vaccine Polyvalent Estimates and Projections (2015-2026)
2.4.3 China Pneumococcal Vaccine Polyvalent Estimates and Projections (2015-2026)
2.4.4 Japan Pneumococcal Vaccine Polyvalent Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Pneumococcal Vaccine Polyvalent Estimates and Projections (2015-2026)
2.4.6 India Pneumococcal Vaccine Polyvalent Estimates and Projections (2015-2026)
3 Global Pneumococcal Vaccine Polyvalent Competition Landscape by Players
3.1 Global Top Pneumococcal Vaccine Polyvalent Players by Sales (2015-2020)
3.2 Global Top Pneumococcal Vaccine Polyvalent Players by Revenue (2015-2020)
3.3 Global Pneumococcal Vaccine Polyvalent Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumococcal Vaccine Polyvalent as of 2019)
3.4 Global Pneumococcal Vaccine Polyvalent Average Price by Company (2015-2020)
3.5 Manufacturers Pneumococcal Vaccine Polyvalent Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Pneumococcal Vaccine Polyvalent Players (Opinion Leaders)
4 Global Pneumococcal Vaccine Polyvalent Market Size by Type
4.1 Global Pneumococcal Vaccine Polyvalent Historic Market Review by Type (2015-2020)
4.1.1 Global Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2015-2020)
4.1.2 Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Type (2015-2020)
4.1.3 Global Pneumococcal Vaccine Polyvalent Price by Type (2014-2020)
4.2 Global Pneumococcal Vaccine Polyvalent Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Pneumococcal Vaccine Polyvalent Sales Forecast by Type (2021-2026)
4.2.2 Global Pneumococcal Vaccine Polyvalent Revenue Forecast by Type (2021-2026)
4.2.3 Global Pneumococcal Vaccine Polyvalent Price Forecast by Type (2021-2026)
5 Global Pneumococcal Vaccine Polyvalent Market Size by Application
5.1 Global Pneumococcal Vaccine Polyvalent Historic Market Review by Application (2015-2020)
5.1.1 Global Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2015-2020)
5.1.2 Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Application (2015-2020)
5.1.3 Global Pneumococcal Vaccine Polyvalent Price by Application (2015-2020)
5.2 Global Pneumococcal Vaccine Polyvalent Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Pneumococcal Vaccine Polyvalent Sales Forecast by Application (2021-2026)
5.2.2 Global Pneumococcal Vaccine Polyvalent Revenue Forecast by Application (2021-2026)
5.2.3 Global Pneumococcal Vaccine Polyvalent Price Forecast by Application (2021-2026)
3 North America Pneumococcal Vaccine Polyvalent Market Facts & Figures
3.2 North America Pneumococcal Vaccine Polyvalent Sales Market Share by Company (2015-2020)
3.3 North America Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2015-2020)
3.4 North America Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2015-2020)
4 Europe Pneumococcal Vaccine Polyvalent Market Facts & Figures
4.2 Europe Pneumococcal Vaccine Polyvalent Sales Market Share by Company (2015-2020)
4.3 Europe Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2015-2020)
4.4 Europe Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2015-2020)
5 China Pneumococcal Vaccine Polyvalent Market Facts & Figures
5.2 China Pneumococcal Vaccine Polyvalent Sales Market Share by Company (2015-2020)
5.3 China Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2015-2020)
5.4 China Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2015-2020)
6 Japan Pneumococcal Vaccine Polyvalent Market Facts & Figures
6.2 Japan Pneumococcal Vaccine Polyvalent Sales Market Share by Company (2015-2020)
6.3 Japan Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2015-2020)
6.4 Japan Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2015-2020)
7 Southeast Asia Pneumococcal Vaccine Polyvalent Market Facts & Figures
7.2 Southeast Asia Pneumococcal Vaccine Polyvalent Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2015-2020)
8 India Pneumococcal Vaccine Polyvalent Market Facts & Figures
8.2 India Pneumococcal Vaccine Polyvalent Sales Market Share by Company (2015-2020)
8.3 India Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2015-2020)
8.4 India Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Pneumococcal Vaccine Polyvalent Business
12.1 Merck & Co.
12.1.1 Merck & Co. Pneumococcal Vaccine Polyvalent Corporation Information
12.1.2 Merck & Co. Pneumococcal Vaccine Polyvalent Business Overview and Total Revenue
12.1.3 Merck & Co. Pneumococcal Vaccine Polyvalent Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Merck & Co. Pneumococcal Vaccine Polyvalent Products Offered
12.1.5 Merck & Co. Recent Development
12.2 Pfizer
12.2.1 Pfizer Pneumococcal Vaccine Polyvalent Corporation Information
12.2.2 Pfizer Pneumococcal Vaccine Polyvalent Business Overview and Total Revenue
12.2.3 Pfizer Pneumococcal Vaccine Polyvalent Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer Pneumococcal Vaccine Polyvalent Products Offered
12.2.5 Pfizer Recent Development
…
13 Pneumococcal Vaccine Polyvalent Manufacturing Cost Analysis
13.1 Pneumococcal Vaccine Polyvalent Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Pneumococcal Vaccine Polyvalent
13.4 Pneumococcal Vaccine Polyvalent Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Pneumococcal Vaccine Polyvalent Distributors List
14.3 Pneumococcal Vaccine Polyvalent Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Pneumococcal Vaccine Polyvalent Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Pneumococcal Vaccine Polyvalent Sales (K MT) Comparison by Application (2020-2026)
Table 3. Global Market Pneumococcal Vaccine Polyvalent Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Pneumococcal Vaccine Polyvalent Sales (K MT) by Region (2015-2020)
Table 5. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Region (2015-2020)
Table 6. Global Pneumococcal Vaccine Polyvalent Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Pneumococcal Vaccine Polyvalent Revenue Share by Region (2015-2020)
Table 8. Global Pneumococcal Vaccine Polyvalent Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Pneumococcal Vaccine Polyvalent Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Pneumococcal Vaccine Polyvalent Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Pneumococcal Vaccine Polyvalent Revenue Share Forecast by Region (2021-2026)
Table 12. Global Pneumococcal Vaccine Polyvalent (K MT) of Key Companies (2015-2020)
Table 13. Global Pneumococcal Vaccine Polyvalent Sales Share by Company (2015-2020)
Table 14. Global Pneumococcal Vaccine Polyvalent Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Pneumococcal Vaccine Polyvalent Revenue Share by Company (2015-2020)
Table 16. Global Pneumococcal Vaccine Polyvalent by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumococcal Vaccine Polyvalent as of 2019)
Table 17. Global Pneumococcal Vaccine Polyvalent Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Pneumococcal Vaccine Polyvalent Manufacturing Sites and Area Served
Table 19. Manufacturers Pneumococcal Vaccine Polyvalent Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Pneumococcal Vaccine Polyvalent Players
Table 22. Global Pneumococcal Vaccine Polyvalent Sales (K MT) by Type (2015-2020)
Table 23. Global Pneumococcal Vaccine Polyvalent Sales Share by Type (2015-2020)
Table 24. Global Pneumococcal Vaccine Polyvalent Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Pneumococcal Vaccine Polyvalent Price (K MT) by Type (2015-2020)
Table 26. Global Pneumococcal Vaccine Polyvalent Sales Share by Type (2021-2026)
Table 27. Global Pneumococcal Vaccine Polyvalent Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Pneumococcal Vaccine Polyvalent Revenue Share by Type (2021-2026)
Table 29. Global Pneumococcal Vaccine Polyvalent Price (K MT) by Type (2021-2026)
Table 30. Global Pneumococcal Vaccine Polyvalent Sales (K MT) by Application (2015-2020)
Table 31. Global Pneumococcal Vaccine Polyvalent Sales Share by Application (2015-2020)
Table 32. Global Pneumococcal Vaccine Polyvalent Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Pneumococcal Vaccine Polyvalent Price (K MT) by Application (2015-2020)
Table 34. Global Pneumococcal Vaccine Polyvalent Sales (K MT) by Application (2021-2026)
Table 35. Global Pneumococcal Vaccine Polyvalent Sales Share by Application (2021-2026)
Table 36. Global Pneumococcal Vaccine Polyvalent Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Pneumococcal Vaccine Polyvalent Revenue Share by Application (2021-2026)
Table 38. Global Pneumococcal Vaccine Polyvalent Price (K MT) by Application (2021-2026)
Table 39. United States Pneumococcal Vaccine Polyvalent Sales (K MT) by Company (2015-2020)
Table 40. United States Pneumococcal Vaccine Polyvalent Sales Market Share by Company (2015-2020)
Table 41. United States Pneumococcal Vaccine Polyvalent Sales (K MT) by Type (2015-2020)
Table 42. United States Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2015-2020)
Table 43. United States Pneumococcal Vaccine Polyvalent Sales (K MT) by Application (2015-2020)
Table 44. United States Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2015-2020)
Table 45. Europe Pneumococcal Vaccine Polyvalent Sales (K MT) by Company (2015-2020)
Table 46. Europe Pneumococcal Vaccine Polyvalent Sales Market Share by Company (2015-2020)
Table 47. Europe Pneumococcal Vaccine Polyvalent Sales (K MT) by Type (2015-2020)
Table 48. Europe Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2015-2020)
Table 49. Europe Pneumococcal Vaccine Polyvalent Sales (K MT) by Application (2015-2020)
Table 50. Europe Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2015-2020)
Table 51. China Pneumococcal Vaccine Polyvalent Sales (K MT) by Company (2015-2020)
Table 52. China Pneumococcal Vaccine Polyvalent Sales Market Share by Company (2015-2020)
Table 53. China Pneumococcal Vaccine Polyvalent Sales (K MT) by Type (2015-2020)
Table 54. China Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2015-2020)
Table 55. China Pneumococcal Vaccine Polyvalent Sales (K MT) by Application (2015-2020)
Table 56. China Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2015-2020)
Table 57. Japan Pneumococcal Vaccine Polyvalent Sales (K MT) by Company (2015-2020)
Table 58. Japan Pneumococcal Vaccine Polyvalent Sales Market Share by Company (2015-2020)
Table 59. Japan Pneumococcal Vaccine Polyvalent Sales (K MT) by Type (2015-2020)
Table 60. Japan Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2015-2020)
Table 61. Japan Pneumococcal Vaccine Polyvalent Sales (K MT) by Application (2015-2020)
Table 62. Japan Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Pneumococcal Vaccine Polyvalent Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Pneumococcal Vaccine Polyvalent Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Pneumococcal Vaccine Polyvalent Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Pneumococcal Vaccine Polyvalent Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2015-2020)
Table 69. India Pneumococcal Vaccine Polyvalent Sales (K MT) by Company (2015-2020)
Table 70. India Pneumococcal Vaccine Polyvalent Sales Market Share by Company (2015-2020)
Table 71. India Pneumococcal Vaccine Polyvalent Sales (K MT) by Type (2015-2020)
Table 72. India Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2015-2020)
Table 73. India Pneumococcal Vaccine Polyvalent Sales (K MT) by Application (2015-2020)
Table 74. India Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2015-2020)
Table 75. Merck & Co. Corporation Information
Table 76. Merck & Co. Description and Business Overview
Table 77. Merck & Co. Pneumococcal Vaccine Polyvalent Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Merck & Co. Pneumococcal Vaccine Polyvalent Product
Table 79. Merck & Co. Recent Development
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Pneumococcal Vaccine Polyvalent Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Pfizer Pneumococcal Vaccine Polyvalent Product
Table 84. Pfizer Recent Development
Table 85. Production Base and Market Concentration Rate of Raw Material
Table 86. Key Suppliers of Raw Materials
Table 87. Pneumococcal Vaccine Polyvalent Distributors List
Table 88. Pneumococcal Vaccine Polyvalent Customers List
Table 89. Market Key Trends
Table 90. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 91. Key Challenges
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Pneumococcal Vaccine Polyvalent Product Picture
Figure 2. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Pneumococcal Vaccine Polyvalent Market Share by Application in 2020 & 2026
Figure 6. 18 years and younger Examples
Figure 7. 19 to 64 years old Examples
Figure 8. 65 years and older Examples
Figure 9. Global Pneumococcal Vaccine Polyvalent Sales (K MT) Growth Rate (2015-2026)
Figure 10. Global Pneumococcal Vaccine Polyvalent Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Pneumococcal Vaccine Polyvalent Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 12. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Pneumococcal Vaccine Polyvalent Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Pneumococcal Vaccine Polyvalent Sales (K MT) Growth Rate (2015-2026)
Figure 16. Europe Pneumococcal Vaccine Polyvalent Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Pneumococcal Vaccine Polyvalent Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Pneumococcal Vaccine Polyvalent Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Pneumococcal Vaccine Polyvalent Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Pneumococcal Vaccine Polyvalent Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Pneumococcal Vaccine Polyvalent Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Pneumococcal Vaccine Polyvalent Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Pneumococcal Vaccine Polyvalent Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Pneumococcal Vaccine Polyvalent Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Pneumococcal Vaccine Polyvalent Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Pneumococcal Vaccine Polyvalent Players Market Share by Revenue in Pneumococcal Vaccine Polyvalent 2015 & 2019
Figure 27. Pneumococcal Vaccine Polyvalent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Pneumococcal Vaccine Polyvalent Revenue Share by Type (2015-2020)
Figure 29. Global Pneumococcal Vaccine Polyvalent Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Pneumococcal Vaccine Polyvalent Revenue Share by Application (2015-2020)
Figure 31. Global Pneumococcal Vaccine Polyvalent Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Pneumococcal Vaccine Polyvalent Sales Market Share by Type in 2019
Figure 33. United States Pneumococcal Vaccine Polyvalent Sales Market Share by Type in 2019
Figure 34. Europe Pneumococcal Vaccine Polyvalent Sales Market Share by Company in 2019
Figure 35. Europe Pneumococcal Vaccine Polyvalent Sales Market Share by Type in 2019
Figure 36. Europe Pneumococcal Vaccine Polyvalent Sales Market Share by Application in 2019
Figure 37. China Pneumococcal Vaccine Polyvalent Sales Market Share by Company in 2019
Figure 38. China Pneumococcal Vaccine Polyvalent Sales Market Share by Type in 2019
Figure 39. China Pneumococcal Vaccine Polyvalent Sales Market Share by Application in 2019
Figure 40. Japan Pneumococcal Vaccine Polyvalent Sales Market Share by Company in 2019
Figure 41. Japan Pneumococcal Vaccine Polyvalent Sales Market Share by Type in 2019
Figure 42. Japan Pneumococcal Vaccine Polyvalent Sales Market Share by Application in 2019
Figure 43. Southeast Asia Pneumococcal Vaccine Polyvalent Sales Market Share by Company in 2019
Figure 44. Southeast Asia Pneumococcal Vaccine Polyvalent Sales Market Share by Type in 2019
Figure 45. Southeast Asia Pneumococcal Vaccine Polyvalent Sales Market Share by Application in 2019
Figure 46. India Pneumococcal Vaccine Polyvalent Sales Market Share by Company in 2019
Figure 47. India Pneumococcal Vaccine Polyvalent Sales Market Share by Type in 2019
Figure 48. India Pneumococcal Vaccine Polyvalent Sales Market Share by Application in 2019
Figure 49. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Key Raw Materials Price Trend
Figure 52. Manufacturing Cost Structure of Pneumococcal Vaccine Polyvalent
Figure 53. Manufacturing Process Analysis of Pneumococcal Vaccine Polyvalent
Figure 54. Pneumococcal Vaccine Polyvalent Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Porter's Five Forces Analysis
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
肺炎球菌ワクチンの世界市場レポート2020 Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40% in 2015. The second place is Europe, following North America with sales market share over 18…- 肺炎球菌ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global Pneumococcal Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.1% in the forecast period of 2020 to 2025 and will expected to reach USD 7551.8 million by 2025, from USD 7242 million in 2019. The Pneumococ…
- 共役ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Conjugate Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate …
- 全ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global All Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data i…
- インフルエンザワクチンの世界市場レポート2020 Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 6…